1. P1530: PERITRANFUSIONAL C1-INHIBITOR IN PATIENTS WITH SEVERE COMPLEMENT-MEDIATED AUTOIMMUNE HEMOLYTIC ANEMIA: AN OPEN LABEL PHASE 2 TRIAL. (23rd June 2022) Authors: de Boer, E. C. W.; Jalink, M.; Delvasto-Nuñes, L.; Meulenbroek, E. M.; Baas, I.; Janssen, S. R.; Dijkman, E. E.; Gelderman, K. A.; Wouters, D.; Engel, M. D.; de Haas, M.; Kersten, M.-J.; Jongerius, I.; Zeerleder, S.; Vos, J. M. Journal: HemaSphere Issue: Volume 6(2022)Supplement 3 Page Start: 1411 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗